Luca Lambertini

Dr. Luca Lambertini


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
Fabrizio Di MaidaFabrizio Di Maida
Fabrizio Di Maida
GCGianmartin Cito
Gianmartin Cito
LLLuca Lambertini
Luca Lambertini
FVFrancesca Valastro
Francesca Valastro
GMGirolamo Morelli
Girolamo Morelli
Andrea CocciAndrea Cocci
Andrea Cocci
Di Maida F, et al. World J Mens Health. 2020 Jan;38:e34. https://doi.org/10.5534/wjmh.200065

1 January 2023 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
AGAntonio Andrea Grosso
Antonio Andrea Grosso
Fabrizio Di MaidaFabrizio Di Maida
Fabrizio Di Maida
SNSamuele Nardoni
Samuele Nardoni
MSMatteo Salvi
Matteo Salvi
SGSofia Giudici
Sofia Giudici
ATAgostino Tuccio
Agostino Tuccio
Grosso AA, et al. World J Mens Health. 2023 Jan;41:e6. https://doi.org/10.5534/wjmh.220042

4 October 2024 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
LLLuca Lambertini
Luca Lambertini
MPMatteo Pacini
Matteo Pacini
RCRuben Sauer Calvo
Ruben Sauer Calvo
LMLuca Morgantini
Luca Morgantini
DCDonato Cannoletta
Donato Cannoletta
SCSimone Crivellaro
Simone Crivellaro

28 December 2024 in Current Oncology
Verified
Journal Article
Open access
PDF file
FLFrancesco Lasorsa
Francesco Lasorsa
ABArianna Biasatti
Arianna Biasatti
AOAngelo Orsini
Angelo Orsini
GBGabriele Bignante
Gabriele Bignante
GFGabriana M. Farah
Gabriana M. Farah
SVSrinivas Vourganti
Srinivas Vourganti
Focal therapy has emerged as a balanced middle ground aiming to reduce overtreatment and the risk of progression, as well as patients’ distress and anxiety. Focal therapy and partial gland ablation prioritize the precise elimination of the index lesion and a surrounding safety margin to optimize treatment outcomes and lower the risk of residual disease. The paradigm of whole-gland ablation has shifted towards more targeted approaches. Several treatment templates ranging from subtotal and hemiablation to “hockey-stick”, quadrant, and even focal lesion ablation have emerged. Many types of energy may be utilized during focal treatment. First, focal therapy can be grossly classified into thermal vs. non-thermal energy. The aim of this non-systematic review is to offer a comprehensive analysis of recently available evidence on focal therapy for PCa.

1 April 2025 in Minerva Urology and Nephrology
Verified
Journal Article
Closed access
LLLuca Lambertini
Luca Lambertini
MPMatteo Pacini
Matteo Pacini
RCRuben S. Calvo
Ruben S. Calvo
JAJuan R. Torres Anguiano
Juan R. Torres Anguiano
DCDonato Cannoletta
Donato Cannoletta
SCSimone Crivellaro
Simone Crivellaro
Article: Retroperitoneal single port vs. transperitoneal multiport robot assisted partial nephrectomy in patients with highly hostile abdomen: comparative analysis from a tertiary care center - Minerva Urology and Nephrology 2025 April;77(2):209-16 - Minerva Medica - Journals

8 November 2023 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
LLLuca Lambertini
Luca Lambertini
FMFabrizio Di Maida
Fabrizio Di Maida
ACAnna Cadenar
Anna Cadenar
SNSamuele Nardoni
Samuele Nardoni
AGAntonio Andrea Grosso
Antonio Andrea Grosso
AMAndrea Minervini
Andrea Minervini